167 related articles for article (PubMed ID: 21062428)
1. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.
Combs SE; Edler L; Burkholder I; Rieken S; Habermehl D; Jäkel O; Haberer T; Unterberg A; Wick W; Debus J; Haselmann R
BMC Cancer; 2010 Nov; 10():615. PubMed ID: 21062428
[TBL] [Abstract][Full Text] [Related]
2. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial.
Deng MY; Maas SLN; Hinz F; Karger CP; Sievers P; Eichkorn T; Meixner E; Hoegen-Sassmannshausen P; Hörner-Rieber J; Lischalk JW; Seidensaal K; Bernhardt D; Jungk C; Unterberg A; Wick A; Wick W; von Deimling A; Sahm F; Combs S; Herfarth K; Debus J; König L
Neuro Oncol; 2024 Apr; 26(4):701-712. PubMed ID: 38079455
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.
Combs SE; Kieser M; Habermehl D; Weitz J; Jäger D; Fossati P; Orrechia R; Engenhart-Cabillic R; Pötter R; Dosanjh M; Jäkel O; Büchler MW; Debus J
BMC Cancer; 2012 Apr; 12():137. PubMed ID: 22472035
[TBL] [Abstract][Full Text] [Related]
6. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.
Combs SE; Habermehl D; Ganten T; Schmidt J; Edler L; Burkholder I; Jäkel O; Haberer T; Debus J
BMC Cancer; 2011 Feb; 11():67. PubMed ID: 21314962
[TBL] [Abstract][Full Text] [Related]
7. Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.
Combs SE; Habermehl D; Kieser M; Dreher C; Werner J; Haselmann R; Jäkel O; Jäger D; Büchler MW; Debus J
BMC Cancer; 2013 Sep; 13():419. PubMed ID: 24034562
[TBL] [Abstract][Full Text] [Related]
8. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.
Rieken S; Habermehl D; Haberer T; Jaekel O; Debus J; Combs SE
Radiat Oncol; 2012 Mar; 7():41. PubMed ID: 22436135
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
10. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
12. Carbon ion radiation therapy for high-risk meningiomas.
Combs SE; Hartmann C; Nikoghosyan A; Jäkel O; Karger CP; Haberer T; von Deimling A; Münter MW; Huber PE; Debus J; Schulz-Ertner D
Radiother Oncol; 2010 Apr; 95(1):54-9. PubMed ID: 20189258
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
[TBL] [Abstract][Full Text] [Related]
15. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
Wenkel E; Thornton AF; Finkelstein D; Adams J; Lyons S; De La Monte S; Ojeman RG; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1363-70. PubMed ID: 11121635
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review of Ion Radiotherapy in Maintaining Local Control Regarding Atypical and Anaplastic Meningiomas.
Coggins WS; Pham NK; Nguyen AV; Branch DW; Guillet JY; Korst G; Lall RR
World Neurosurg; 2019 Dec; 132():282-291. PubMed ID: 31476452
[TBL] [Abstract][Full Text] [Related]
19. Volumetric response of intracranial meningioma after photon or particle irradiation.
Mozes P; Dittmar JO; Habermehl D; Tonndorf-Martini E; Hideghety K; Dittmar A; Debus J; Combs SE
Acta Oncol; 2017 Mar; 56(3):431-437. PubMed ID: 27911139
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
